“Restoring Skin Barrier Function: New Treatment for Netherton Syndrome”

In Clinical Development, Featured on App, Orphan Drug Congress, Partnering & Investment by Freya Smale

Jean Nordstrom of Sixera Pharma AB  joined us for World Orphan Drug Congress USA 2015 to present about ‘ Restoring Skin Barrier Function: New Treatment for Netherton Syndrome’ .
Download the presentation now to learn about:

  • Unmet medical need and market
  • In Vivo proof of principle
  • Project status and next steps 
  • Opportunity
…and much more!
Get your copy here!
To find out more about how Sixera Pharma AB’s new treatment for Netherton Syndrome , join us at  World Orphan Drug Congress USA 2016 April 20-22  in Washington, DC.